Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)

被引:0
|
作者
E. Peel
Y. Cheng
J. T. Djordjevic
S. Fox
T. C. Sorrell
K. Belov
机构
[1] Faculty of Veterinary Science,Department of Primary Industries
[2] The University of Sydney,undefined
[3] Centre for Infectious Diseases and Microbiology,undefined
[4] The Westmead Institute for Medical Research,undefined
[5] and Marie Bashir Institute for Infectious Diseases and Biosecurity,undefined
[6] University of Sydney,undefined
[7] Parks,undefined
[8] Water and Environment,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tasmanian devil joeys, like other marsupials, are born at a very early stage of development, prior to the development of their adaptive immune system, yet survive in a pathogen-laden pouch and burrow. Antimicrobial peptides, called cathelicidins, which provide innate immune protection during early life, are expressed in the pouch lining, skin and milk of devil dams. These peptides are active against pathogens identified in the pouch microbiome. Of the six characterised cathelicidins, Saha-CATH5 and 6 have broad-spectrum antibacterial activity and are capable of killing problematic human pathogens including methicillin-resistant S. aureus and vancomycin-resistant E. faecalis, while Saha-CATH3 is active against fungi. Saha-CATH5 and 6 were toxic to human A549 cells at 500 μg/mL, which is over seven times the concentration required to kill pathogens. The remaining devil cathelicidins were not active against tested bacterial or fungal strains, but are widely expressed throughout the body, such as in immune tissues, in digestive, respiratory and reproductive tracts, and in the milk and pouch, which indicates that they are likely also important components of the devil immune system. Our results suggest cathelicidins play a role in protecting naive young during pouch life by passive immune transfer in the milk and may modulate pouch microbe populations to reduce potential pathogens.
引用
收藏
相关论文
共 50 条
  • [31] Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii
    Hawkins, C. E.
    Baars, C.
    Hesterman, H.
    Hocking, G. J.
    Jones, M. E.
    Lazenby, B.
    Mann, D.
    Mooney, N.
    Pemberton, D.
    Pyecroft, S.
    Restani, M.
    Wiersma, J.
    [J]. BIOLOGICAL CONSERVATION, 2006, 131 (02) : 307 - 324
  • [32] The pathology of devil facial tumor disease (DFTD) in Tasmanian devils (Sarcophilus harrisii)
    Loh, R.
    Bergfeld, J.
    Hayes, D.
    O'Hara, A.
    Pyecroft, S.
    Raidal, S.
    Sharpe, R.
    [J]. VETERINARY PATHOLOGY, 2006, 43 (06) : 890 - 895
  • [33] BODY TEMPERATURES IN TASMANIAN DEVIL, SARCOPHILUS-HARRISII (MARSUPIALIA-DASYURIDAE)
    GUILER, ER
    HEDDLE, RWL
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY, 1974, 47 (3A): : 981 - 989
  • [34] Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil)
    Miller, Webb
    Hayes, Vanessa M.
    Ratan, Aakrosh
    Petersen, Desiree C.
    Wittekindt, Nicola E.
    Miller, Jason
    Walenz, Brian
    Knight, James
    Qi, Ji
    Zhao, Fangqing
    Wang, Qingyu
    Bedoya-Reina, Oscar C.
    Katiyar, Neerja
    Tomsho, Lynn P.
    Kasson, Lindsay McClellan
    Hardie, Rae-Anne
    Woodbridge, Paula
    Tindall, Elizabeth A.
    Bertelsen, Mads Frost
    Dixon, Dale
    Pyecroft, Stephen
    Helgen, Kristofer M.
    Lesk, Arthur M.
    Pringle, Thomas H.
    Patterson, Nick
    Zhang, Yu
    Kreiss, Alexandre
    Woods, Gregory M.
    Jones, Menna E.
    Schuster, Stephan C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (30) : 12348 - 12353
  • [35] DISTRIBUTION OF ACID PHOSPHATASE IN TASMANIAN DEVIL, SARCOPHILUS-HARRISII (MARSUPIALIA DASYURIDAE)
    PARSONS, RS
    HEDDLE, RWL
    GUILER, ER
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY, 1971, 39 (2B): : 219 - &
  • [36] Growth and development of the Tasmanian devil (Sarcophilus harrisii) at Healesville Sanctuary, Victoria, Australia
    Phillips, BT
    Jackson, SM
    [J]. ZOO BIOLOGY, 2003, 22 (05) : 497 - 505
  • [37] The reproductive cycle of the Tasmanian devil (Sarcophilus harrisii) and factors associated with reproductive success in captivity
    Keeley, T.
    O'Brien, J. K.
    Fanson, B. G.
    Masters, K.
    McGreevy, P. D.
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2012, 176 (02) : 182 - 191
  • [38] Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity
    Kreiss, Alexandre
    Cheng, Yuanyuan
    Kimble, Frank
    Wells, Barrie
    Donovan, Shaun
    Belov, Katherine
    Woods, Gregory M.
    [J]. PLOS ONE, 2011, 6 (07):
  • [39] Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii)
    Patchett, Amanda L.
    Coorens, Tim H. H.
    Darby, Jocelyn
    Wilson, Richard
    McKay, Matthew J.
    Kamath, Karthik S.
    Rubin, Alan
    Wakefield, Matthew
    Mcintosh, Lachlan
    Mangiola, Stefano
    Pye, Ruth J.
    Flies, Andrew S.
    Corcoran, Lynn M.
    Lyons, A. Bruce
    Woods, Gregory M.
    Murchison, Elizabeth P.
    Papenfuss, Anthony T.
    Tovar, Cesar
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (09) : 1847 - 1858
  • [40] The effects of season and devil facial tumour disease on the reproductive physiology of the male Tasmanian devil (Sarcophilus harrisii)
    Keeley, T.
    McGreevy, P. D.
    O'Brien, J. K.
    [J]. REPRODUCTION FERTILITY AND DEVELOPMENT, 2012, 24 (07) : 999 - 1007